Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/22/1997 | EP0754236A1 Reduction of endogenous seed protein levels in plants |
01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
01/22/1997 | EP0754226A1 Recombinant equine herpesviruses |
01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
01/22/1997 | EP0754195A1 Btf2 complex proteins and uses thereof |
01/22/1997 | EP0754194A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
01/22/1997 | EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
01/22/1997 | EP0754192A1 Circularly permuted ligands and circularly permuted chimeric molecules |
01/22/1997 | EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
01/22/1997 | EP0754054A1 Antirestenosis protein |
01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
01/22/1997 | EP0555438B1 Streptolysin o variants |
01/22/1997 | EP0528858B1 Inhibitors of dipeptidyl-aminopeptidase type iv |
01/22/1997 | EP0502979B1 Beta retinoic acid response elements compositions and assays |
01/22/1997 | EP0502107B1 Type-b rotavirus cultures and uses thereof |
01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
01/22/1997 | CN1141061A Thrombopoietin |
01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
01/22/1997 | CN1141000A Vaccine design and production |
01/22/1997 | CN1140999A Anti-fungal methods and materials |
01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
01/21/1997 | US5596132 Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene |
01/21/1997 | US5596089 Oligonucleotide probe and primers specific to bovine or porcine male genomic DNA |
01/21/1997 | US5596088 DNA Encoding the human P2U receptor and null cells expressing P2U receptors |
01/21/1997 | US5596082 Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process |
01/21/1997 | US5596080 Heating in the presence of water |
01/21/1997 | US5596079 Mimetics of senescent cell derived inhibitors of DNA synthesis |
01/21/1997 | US5596072 Method of refolding human IL-13 |
01/21/1997 | US5596071 Bacillus thuringiensis toxins active against hymenopteran pests |
01/21/1997 | US5595972 Polypeptides for signals |
01/21/1997 | US5595969 Complexed with antiinflammatory agent, drug delivery |
01/21/1997 | US5595913 Lipid fractionation |
01/21/1997 | US5595912 Genetic vectors and rna codes |
01/21/1997 | US5595903 Expression vectors, host cells |
01/21/1997 | US5595901 Method for obtaining protective active and inactive adenylate cyclase from Bordetella parapertussis |
01/21/1997 | US5595898 Cdna genetic sequences |
01/21/1997 | US5595895 Efficient directional genetic cloning system |
01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
01/21/1997 | US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
01/21/1997 | US5595886 Gene expression in eukaryotic cell, treatment of hemophilia |
01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
01/21/1997 | US5595884 Papillomavirus E2 transactivation repressor proteins and DNA |
01/21/1997 | US5595882 Angiotensin II type-1 receptor proteins and screening assays using such proteins or transformants expressing them |
01/21/1997 | US5595880 DNA encoding an α2B adrenergic receptor and uses thereof |
01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
01/21/1997 | US5595873 T. thermophila group I introns that cleave amide bonds |
01/21/1997 | US5595872 Dna sequences, cells and expression vectors |
01/21/1997 | US5595871 Detection and prevention of mycoplasma hominis infection |
01/21/1997 | US5595869 Diagnostic methods for detecting lymphomas in humans |
01/21/1997 | US5595741 Aminoalkylmaleimides and hapten and antigen derivatives derived therefrom as well as conjugates with peptides or proteins |
01/21/1997 | US5595740 Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens |
01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
01/21/1997 | US5595737 Leukocyte adhesion molecule, distinction between bound and shed molecule |
01/21/1997 | US5595734 Compositions comprising ONCONASE (tm) and lovastatin |
01/21/1997 | US5595733 Methods for protecting ZEA mays plants against pest damage |
01/21/1997 | US5595732 Polyethylene-protein conjugates |
01/21/1997 | US5595722 Transforming growth factor-beta activators |
01/21/1997 | US5595721 Using antibodies directed to an antigen and radioactive labels |
01/21/1997 | CA2097821C Ganoderma lucidum iy009 which produces proteoglycan(g009) having effect of enhancing antitumor immunity |
01/21/1997 | CA1338874C Process for obtaining active proteins from a biologically inactive form |
01/21/1997 | CA1338859C Expression system |
01/16/1997 | WO1997001648A1 A novel human protein critical for hiv replication |
01/16/1997 | WO1997001647A2 Dna sequences for identifying highly transmissible lineages of pseudomonas (burkholderia) cepacia |
01/16/1997 | WO1997001642A1 Modified proteins and methods of their production |
01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
01/16/1997 | WO1997001637A1 Process for the microbial production of amino acids using recombinant micro-organisms with raised secretion rate |
01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
01/16/1997 | WO1997001635A1 Bax omega protein and methods |
01/16/1997 | WO1997001634A2 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
01/16/1997 | WO1997001633A1 Cytokine that induces apoptosis |
01/16/1997 | WO1997001579A2 Somatostatin peptides |
01/16/1997 | WO1997001578A1 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides |
01/16/1997 | WO1997001577A1 Ion channel |
01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
01/16/1997 | WO1997001574A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
01/16/1997 | WO1997001573A2 Early onset alzheimer's disease gene and gene products |
01/16/1997 | WO1997001572A1 Sequences for production of 2,4-diacetylphloroglucinol and methods |
01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
01/16/1997 | WO1997001351A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
01/16/1997 | WO1996037610A3 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
01/16/1997 | WO1996037607A3 Nucleic acid with a polymorphic domain of a b2 bradykinin receptor gene |
01/16/1997 | WO1996036702A3 Soluble, active hepatitis c virus protease |
01/16/1997 | WO1996034954A3 Biotin-binding containment systems |
01/16/1997 | WO1996034887A3 Antisense peptides |
01/16/1997 | WO1996034113A3 Methods for the identification of farnesyltransferase inhibitors |
01/16/1997 | WO1996027677A3 Method of purification of recombinant viral vectors containing a therapeutic gene |
01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |